Latest in Skin Care

Molecule discovery holds promise for gene therapies for psoriasis

Scientists at the University of Birmingham have discovered a protein that could hold the key to novel gene therapies for skin problems including psoriasis – a common, chronic skin disease that affects over 100 million people worldwide

Find out more
Molecule discovery holds promise for gene therapies for psoriasis

You need to be a subscriber to read this article.
Click here to find out more.
Artificial intelligence in pharmaceutical inspection: improving quality with better algorithms

Artificial intelligence in pharmaceutical inspection: improving quality with better algorithms

ROVIS helps pharmaceutical manufacturers to improve inspection quality, reduce false rejects and cut waste with robotics, advanced software and AI
See more
Global dermatology market set to reach US$33.7bn by 2022, despite patent expiries

Global dermatology market set to reach US$33.7bn by 2022, despite patent expiries

Growth will be driven by a strong late-stage pipeline, which includes several highly valuable targeted therapies
Allergan acquires Topokine Therapeutics to focus on non-invasive fat reduction programme

Allergan acquires Topokine Therapeutics to focus on non-invasive fat reduction programme

Acquisition adds to Allergan's robust mid-to-late stage pipeline and reinforces its leadership in aesthetics innovation
Animal-free approach to metabolism studies

Animal-free approach to metabolism studies

For assessing the effect of candidate drugs and consumer use chemicals in human skin
Researchers invent novel microneedle patch

Researchers invent novel microneedle patch

National University of Singapore research team develops simple technique for faster and more effective delivery of painkiller and collagen
Venn Life Sciences acquires trading assets of Evocutis

Venn Life Sciences acquires trading assets of Evocutis

Including intellectual property rights to Labskin and anti-acne compound SYN1113
Merz Pharma acquires Swiss dermatology company Neocutis

Merz Pharma acquires Swiss dermatology company Neocutis

Will strengthen its aesthetics business, and particularly its business in the US
UK-Norwegian team to develop living skin equivalent testing model

UK-Norwegian team to develop living skin equivalent testing model

For testing inflammatory responses
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence

Latest posts in Skin Care

Evocutis and Bradford University Collaborate on pigmented LabSkin

Evocutis and Bradford University Collaborate on pigmented LabSkin

Aim to discover improved ways of investigating common pigment-related skin conditions
Beiersdorf and Charité Berlin discover ‘inner clock’ in skin cells

Beiersdorf and Charité Berlin discover ‘inner clock’ in skin cells

Provides new prospects for skin care and medicine
Evocutis secures first contracts for LabSkin living skin equivalent

Evocutis secures first contracts for LabSkin living skin equivalent

Offers an alternative to ethically sensitive and expensive animal and human volunteer testing
Evocutis joins European platform to promote alternatives to animal testing

Evocutis joins European platform to promote alternatives to animal testing

After making presentation about its LabSkin technology
DKSH acquires Tiger Chemicals Company

DKSH acquires Tiger Chemicals Company

Strengthens its footprint in Australia and New Zealand
Butterfly pack ensures accurate product dosing

Butterfly pack ensures accurate product dosing

Requires only one hand to open
Sanofi sells Dermik to Valeant of Canada

Sanofi sells Dermik to Valeant of Canada

Valeant also acquires Laval manufacturing site
Syntopix plans to buy Leeds Skin

Syntopix plans to buy Leeds Skin

Key attraction of acquisition is Leeds Skin’s LabSkin technology
Lubrizol acquires Nalco’s personal care business

Lubrizol acquires Nalco’s personal care business

Nalco to concentrate on core business
Syntopix to develop new microemulsions

Syntopix to develop new microemulsions

Wins support from Intelligent Formulation
AmStem begins consumer study of human stem cell cosmeceutical

AmStem begins consumer study of human stem cell cosmeceutical

Korean stem cell research specialist studies SteMixx as prelude to US IRB trial

Sponsor content

Intertek Clinical Research Services moves to new laboratory facility

Intertek Clinical Research Services moves to new laboratory facility

Intertek Clinical Research Services has more than doubled the size of its laboratory, enabling it to accommodate and deliver larger projects for its customers